Skip to main content
. 2015 May 5;151(2):393–403. doi: 10.1007/s10549-015-3408-1

Table 3.

Two-year cumulative incidence of mild swelling (RVC 5- < 10 % RVC) overall and by chemotherapy group

N 2-Year cumulative incidence (%) 95 % Confidence interval
Entire cohort 1121 16.37 14.22–18.80
No chemotherapy 735 14.64 12.20–17.53
Non-taxane chemotherapy 62 7.05 2.71–17.71
Taxane-based chemotherapy 324 22.76 18.19–28.28